AKYA - Akoya Biosciences, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Specialty Instruments - Laboratory Analytical Instruments - AKYA (1711933)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
24 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2024-06-11
AKYAMcKelligon BrianPres, CEOS - Sale+OE$2.08-7,500224,733-3%-$15,630
D
2024-06-06
AKYAMcKelligon BrianPres, CEOS - Sale+OE$2.01-7,500224,733-3%-$15,064
D
2024-03-20
AKYAMcKelligon BrianPres, CEOS - Sale+OE$4.97-7,500231,868-3%-$37,243
AD
2024-03-13
AKYAMcKelligon BrianPres, CEOS - Sale+OE$4.94-7,500231,868-3%-$37,043
2024-03-13
AKYAMcKelligon BrianPres, CEOS - Sale$4.94-7,500224,368-3%-$37,035
D
2023-12-19
AKYAMcKelligon BrianPres, CEOS - Sale+OE$4.48-7,500152,563-5%-$33,566
D
2023-12-12
AKYAMcKelligon BrianPres, CEOS - Sale+OE$4.25-7,500152,563-5%-$31,871
D
2023-11-20
AKYAMcKelligon BrianPres, CEOS - Sale+OE$4.39-7,500152,563-5%-$32,901
2023-09-07
AKYAPla FredericCOOP - Purchase$4.60+20,00060,555+49%+$92,014
2023-06-12
AKYAEk John FrederickCFOP - Purchase$5.00+20,000180,000+13%+$100,000
2023-06-12
AKYALai Goldman MylaDirP - Purchase$5.00+20,00020,000New+$100,000
2023-06-12
AKYAMendel ScottDirP - Purchase$5.00+20,00028,500+235%+$100,000
2023-06-12
AKYAWinkler MatthewDirP - Purchase$5.00+203,388984,513+26%+$1,016,940
2023-06-12
AKYAShepler Robert GDirP - Purchase$5.00+120,000369,592+48%+$600,000
2023-06-12
AKYARaffin Thomas A.DirP - Purchase$5.00+2,020,00016,172,127+14%+$10,100,000
D
2023-06-06
AKYAMcKelligon BrianPres, CEOS - Sale+OE$5.71-5,000152,563-3%-$28,537
A
2022-12-13
AKYANolan Garry Ph.D.DirS - Sale$13.25-100555,0840%-$1,325
D
2023-03-14
AKYAMcKelligon BrianPres, CEOS - Sale+OE$9.17-5,000160,000-3%-$45,852
2022-12-13
AKYASchnettler Thomas PDirS - Sale$13.03-71,0502,742,721-3%-$925,782
D
2022-12-14
AKYADriscoll JosephCFOS - Sale+OE$12.54-24,61312,500-66%-$308,706
2021-12-13
AKYANolan Garry Ph.D.DirS - Sale$13.25-100555,0840%-$1,325
D
2022-12-06
AKYAMcKelligon BrianPres, CEOS - Sale+OE$12.08-5,00080,000-6%-$60,415
2022-12-02
AKYANolan Garry Ph.D.DirS - Sale$13.25-1,100591,9780%-$14,575
2022-12-01
AKYANolan Garry Ph.D.DirS - Sale$13.36-5,000593,078-1%-$66,788

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top